Axel Schörling — CEO
Get alerts when Axel Schörling trades
Alerts for a single person aren't available yet, so you'll follow the companies where they're an insider: EQL Pharma AB.
12-month summary
Net seller over the last 12 months
0 open-market buys, 1 sale, 0 share awards · SEK 0.00 bought, SEK 1,234,585.80 sold
Roles
23.08.2025 – 27.03.2026
Transactions (including via associated entities)
| Date | Issuer | Transaction type | Volume | Price | Value | Source |
|---|---|---|---|---|---|---|
| 27.03.2026 | EQL Pharma AB Stockholm | SoldDisposal | 24,066 | SEK 51.30 | SEK 1,234,585.80 | ↗ |
| 08.09.2025 | EQL Pharma AB Stockholm | Pledge | 289,155 | — | No cash value 289,155 shares | ↗ |
| 05.09.2025 | EQL Pharma AB Stockholm | Option exercise | 400,000 | — | No cash value 400,000 units | ↗ |
| 05.09.2025✎ | EQL Pharma AB Stockholm | Option exercise | 400,000 | SEK 67.50 | SEK 27,000,000.00 | ↗ |
| 03.09.2025 | EQL Pharma AB Stockholm | Pledge | 289,155 | — | No cash value 289,155 shares | ↗ |
| 03.09.2025 | EQL Pharma AB Stockholm | SoldDisposal | 289,155 | SEK 81.00 | SEK 23,421,555.00 | ↗ |
| 23.08.2025 | EQL Pharma AB Stockholm | New shares (subscription) | 100,000 | SEK 7.38 | SEK 738,000.00 | ↗ |